+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuroendocrine Carcinoma"

Neuroendocrine Tumor Treatment Market Size, Share & Trends Analysis Report By Type, By Product, By Site, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Size, Share & Trends Analysis Report By Type, By Product, By Site, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • December 2024
  • 100 Pages
  • Global
From
Neuroendocrine Tumors Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 171 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report 2025 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Neuroendocrine Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Neuroendocrine Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 280 Pages
  • Global
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Neuroendocrine Tumors Market - Product Thumbnail Image

Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Thumbnail Image

Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • June 2024
  • 300 Pages
  • Global
From
Gastro Esophageal Junction Neuroendocrine Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Gastro Esophageal Junction Neuroendocrine Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Gastric Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Gastro-Esophageal Junction Neuroendocrine Tumor (GEJ-NET) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastro-Esophageal Junction Neuroendocrine Tumor (GEJ-NET) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Pipeline Insight, 2024 - Product Thumbnail Image

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gastric Neuroendocrine Tumors Market - Product Thumbnail Image

Gastric Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 - Product Thumbnail Image

Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028

  • Report
  • December 2024
  • 90 Pages
  • Global
From
Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 - Product Thumbnail Image

Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030

  • Report
  • November 2024
  • 600 Pages
  • Global
From
Lutetium-177 Market by Application (Cancer Treatment, Palliative Care, Radiopharmaceutical Therapy), Type (Carrier-Added Lutetium-177, No-Carrier-Added Lutetium-177), End-user, Production, Delivery Form, Developing Technologies - Global Forecast 2025-2030 - Product Thumbnail Image

Lutetium-177 Market by Application (Cancer Treatment, Palliative Care, Radiopharmaceutical Therapy), Type (Carrier-Added Lutetium-177, No-Carrier-Added Lutetium-177), End-user, Production, Delivery Form, Developing Technologies - Global Forecast 2025-2030

  • Report
  • November 2024
  • 186 Pages
  • Global
From
Somatostatin Analogs Market by Type, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Somatostatin Analogs Market by Type, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 195 Pages
  • Global
From
MTOR (Mammalian Target of Rapamycin) Inhibitors - Global Strategic Business Report - Product Thumbnail Image

MTOR (Mammalian Target of Rapamycin) Inhibitors - Global Strategic Business Report

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator

Neuroendocrine carcinoma (NEC) is a rare type of cancer that affects the neuroendocrine system, which is responsible for the production of hormones. It is a type of cancer that is often difficult to diagnose and treat. Treatment options for NEC include surgery, chemotherapy, radiation therapy, and targeted therapies. Oncology drugs are used to treat NEC, and they can be used alone or in combination with other treatments. These drugs can help to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of recurrence. The Neuroendocrine Carcinoma market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of NEC, the development of new treatments, and the increasing availability of targeted therapies. Companies in the market include Novartis, Pfizer, Merck, AstraZeneca, and Roche. Show Less Read more